Toxogonin: oral administration to man.
D000110:Acetylcholinesterase / Q000506:poisoning; D000284:Administration, Oral; D000328:Adult; D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators / Q000008:administration & dosage / Q000097:blood*; D002986:Clinical Trials as Topic; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D007408:Intestinal Absorption; D008297:Male; D009768:Obidoxime Chloride / Q000008:administration & dosage / Q000097:blood; D010091:Oximes / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood* / Q000652:urine; D011220:Pralidoxime Compounds / Q000008:administration & dosage; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D002801:Cholinesterase Reactivators; D010091:Oximes; D011220:Pralidoxime Compounds; D009768:Obidoxime Chloride; D000110:Acetylcholinesterase